Suchergebnisse - "Ager, Casey R"

PubPharm (22)

1

Identification of Nonfunctional Alternatively Spliced Isoforms of STING in Human Acute Myeloid Leukemia

enthalten in: Cancer research communications | 2024

von Boda, A. | Liu, A. | Castro-Pando, S. | +7

2

Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration

enthalten in: JCI insight | 2024

von Liu, A. | Gammon, S. | Pisaneschi, F. | +5

3

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer

enthalten in: Cancer cell | 2023

von Hawley, J. | Obradovic, A. | Dallos, M. | +18

4

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

enthalten in: Journal for immunotherapy of cancer | 2023

von Ager, C. | Zhang, M. | Chaimowitz, M. | +11

UpdateOf: bioRxiv. 2023 Jan 02;:. - PMID 36711647

5

The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity

enthalten in: Cancer cell | 2023

von Ho, P. | Melms, J. | Rogava, M. | +30

6

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

enthalten in: bioRxiv.org | 2023

von Ager, C. | Zhang, M. | Chaimowitz, M. | +9

7

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response

enthalten in: bioRxiv : the preprint server for biology | 2023

von Ager, C. | Zhang, M. | Chaimowitz, M. | +9

UpdateIn: J Immunother Cancer. 2023 Sep;11(9):. - PMID 37657842

8

Single-Cell RNAseq Analysis Reveals Robust, Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer

enthalten in: bioRxiv.org | 2022

von Hawley, J. | Obradovic, A. | Dallos, M. | +17

9

The CD58:CD2 axis is co-regulated with PD-L1 via CMTM6 and governs anti-tumor immunity

enthalten in: bioRxiv.org | 2022

von Ho, P. | Melms, J. | Rogava, M. | +23

10

High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege

enthalten in: Journal for immunotherapy of cancer | 2021

von Ager, C. | Boda, A. | Rajapakshe, K. | +11